Latest statistics and disclosures from Ulys's latest quarterly 13F-HR filing:

  • Top 5 stock holdings are Lexicon Pharmaceuticals. These five stock positions account for 100.00% of Ulys's total stock portfolio.
  • Reduced shares in these 1 stocks: Ceres.
  • Sold out of its positions in Ceres.
  • As of Sept. 30, 2016, Ulys has $78.08M in assets under management (AUM). Assets under management grew from a total value of $62.01M to $78.08M.
  • Independent of market fluctuations, Ulys was a net seller by $1984 worth of stocks in the most recent quarter.

Ulys portfolio companies for September 2016 quarter

Company (Ticker) Portfolio Weight Share Count Price Last Trade
Lexicon Pharmaceuticals 100.00 4.32M 18.07 0.00

Past 13F-HR SEC Filings for Ulys

View All Filings